» Articles » PMID: 10852745

Increased Levels of Circulating Interleukin-18 in Patients with Advanced Tuberculosis

Overview
Specialty Critical Care
Date 2000 Jun 14
PMID 10852745
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-18 (IL-18) has recently been identified as an interferon- gamma-inducing factor and it plays an important role in the Th1 response. We measured serum levels of IL-18 and interferon-gamma (IFN-gamma) in 43 patients with pulmonary tuberculosis and 25 healthy control subjects. Significantly increased levels of circulating IL-18 and IFN-gamma were found in pulmonary tuberculosis as compared with those in healthy control subjects. Circulating IL-18 and IFN-gamma correlated with the extent of disease in pulmonary tuberculosis. We found significantly increased levels of circulating IL-18 and IFN-gamma in the patients with high-grade fever. Circulating IL-18 significantly correlated with circulating IFN-gamma. IL-18 may play an important role in immune response to human infection with Mycobacterium tuberculosis.

Citing Articles

The importance of inflammatory biomarkers in detecting and managing latent tuberculosis infection.

Gunasekaran H, Ranganathan U, Bethunaickan R Front Immunol. 2025; 16:1538127.

PMID: 39981231 PMC: 11839662. DOI: 10.3389/fimmu.2025.1538127.


Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.

Endale Mangamba L, Sike C, Tochie J, Dalle G, Nkouagmi N, Balkissou A Pan Afr Med J. 2023; 44:204.

PMID: 37484595 PMC: 10362651. DOI: 10.11604/pamj.2023.44.204.38541.


Cytokine/chemokine profiles in people with recent infection by .

Herrera M, Keynan Y, Lopez L, Marin D, Velez L, McLaren P Front Immunol. 2023; 14:1129398.

PMID: 37261336 PMC: 10229054. DOI: 10.3389/fimmu.2023.1129398.


Low circulatory Fe and Se levels with a higher IL-6/IL-10 ratio provide nutritional immunity in tuberculosis.

Kaushik S, Sahu S, Guha H, Saha S, Das R, Kupa R Front Immunol. 2023; 13:985538.

PMID: 36713405 PMC: 9878310. DOI: 10.3389/fimmu.2022.985538.


The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes.

Chidambaram V, Gupte A, Wang J, Golub J, Karakousis P Clin Infect Dis. 2020; 73(9):e3409-e3418.

PMID: 32971534 PMC: 8563167. DOI: 10.1093/cid/ciaa1446.